Related Experiment Video
Updated: Aug 2, 2026

Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection
Published on: September 14, 2019
Microsporidial AIDS cholangiopathy due to Encephalitozoon intestinalis: case report and review
R A Sheikh1, T P Prindiville, S Yenamandra
1Department of Internal Medicine, University of California Davis, Sacramento 95932, USA.
Abstract:
Microsporidia are increasingly recognized as opportunistic infections in immunodeficient patients, predominantly patients with AIDS. The two microsporidia most commonly associated with disease in AIDS patients are Enterocytozoon bieneusi and Encephalitozoon intestinalis (previously known as Septata intestinalis). The most common clinical presentation of microsporidiosis in AIDS patients is diarrhea, most commonly caused by the Enterocytozoon bieneusi species. Encephalitozoon intestinalis is a recently described species that has been reported to cause disseminated human infection including cholangitis. We report a case of AIDS cholangiopathy that presented with abdominal pain and cholestatic liver tests. Ultrasound examination and ERCP revealed a picture of sclerosing cholangitis. Bile samples obtained at ERCP were negative for microsporidia; stool studies for microsporidia and cryptosporidia were also negative. No organisms were identified on routine light microscopy of the biopsy specimens from the duodenum, ampulla, and bile duct. E. intestinalis spores were demonstrated in the bile duct biopsies, by methylene blue and azure 11 staining and confirmed by electron microscopy. Albendazole therapy was successful in eradicating E. intestinalis with clinical improvement and improvement in CD4 count. However, the cholangiographic picture did not improve and repeat cholangiography revealed progressive bile duct injury. Albendazole therapy was delayed and may have been too late to prevent bile duct damage; the drug had to be approved by the US Food and Drug Administration for compassionate use. This is an unusual case of sclerosing cholangitis caused by an unusual organism and requiring biliary sphincterotomy and stent placement for progressive stricturing despite eradication of the infection.
Insights
Encephalitozoon intestinalis, a microsporidian, caused AIDS cholangiopathy in an immunocompromised patient. Early albendazole treatment improved symptoms and CD4 count, but bile duct damage persisted.
Area of Science:
- Medical Mycology
- Gastroenterology
- Infectious Diseases
Background:
- Microsporidia are opportunistic pathogens, frequently affecting immunocompromised individuals, particularly those with Acquired Immunodeficiency Syndrome (AIDS).
- Enterocytozoon bieneusi and Encephalitozoon intestinalis are the primary microsporidian species causing disease in AIDS patients, with diarrhea being the most common symptom.
- Encephalitozoon intestinalis has been implicated in disseminated infections, including cholangitis, a condition affecting the bile ducts.
Observation:
- A case of AIDS cholangiopathy presented with abdominal pain and cholestatic liver tests, mimicking sclerosing cholangitis.
- Initial diagnostic tests, including bile and stool samples, were negative for microsporidia. Routine microscopy of biopsy specimens also failed to identify the organism.
- Encephalitozoon intestinalis spores were definitively identified in bile duct biopsies using specialized staining and electron microscopy.
Findings:
- Albendazole therapy successfully eradicated Encephalitozoon intestinalis, leading to clinical improvement and an increased CD4 count.
- Despite successful infection eradication, the cholangiographic findings showed progressive bile duct injury, indicating irreversible damage.
- The delay in albendazole administration, requiring compassionate use approval, may have contributed to the persistent bile duct damage.
Implications:
- This case highlights Encephalitozoon intestinalis as an unusual cause of sclerosing cholangitis in AIDS patients.
- Early diagnosis and prompt treatment with albendazole are crucial for managing microsporidial infections, though they may not reverse established biliary damage.
- Management of such cases may necessitate interventions like biliary sphincterotomy and stent placement to address progressive bile duct stricturing.
Related Concept Videos
Fungal Phylum Microsporidia
Toxoplasmosis
Giardiasis
Amebiasis
Encephalitis l: Introduction
Hepatic Encephalopathy

